|
|
|
|
MB Yin, SF Zakrzewski and MT Hakala
This article has been cited by other articles:
![]() |
V. Cohen, V. Panet-Raymond, N. Sabbaghian, I. Morin, G. Batist, and R. Rozen Methylenetetrahydrofolate Reductase Polymorphism in Advanced Colorectal Cancer: A Novel Genomic Predictor of Clinical Response to Fluoropyrimidine-based Chemotherapy Clin. Cancer Res., May 1, 2003; 9(5): 1611 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pectasides, M. Pectasides, D. Farmakis, N. Bountouroglou, M. Nikolaou, M. Koumpou, N. Mylonakis, and C. Kosmas Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study Ann. Onc., April 1, 2003; 14(4): 537 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schwartz, T. R. Johnson, A. Goetz, H. Burris, L. Smetzer, T. Lampkin, J. Sailstad, J. A. Hohneker, D. D. Von Hoff, and E. K. Rowinsky A Phase I and Pharmacokinetic Study of 1843U89, a Noncompetitive Inhibitor of Thymidylate Synthase, in Patients with Advanced Solid Malignancies Clin. Cancer Res., July 1, 2001; 7(7): 1901 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J.A. Harte, J. C. Matthews, S. M. O'Reilly, D.W. O. Tilsley, S. Osman, G. Brown, S. J. Luthra, F. Brady, T. Jones, and P. M. Price Tumor, Normal Tissue, and Plasma Pharmacokinetic Studies of Fluorouracil Biomodulation With N-Phosphonacetyl-L-aspartate, Folinic Acid, and Interferon Alfa J. Clin. Oncol., May 1, 1999; 17(5): 1580 - 1580. [Abstract] [Full Text] [PDF] |
||||